awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q31119290-87924D99-F092-4507-97C9-2502084954A8
Q31119290-87924D99-F092-4507-97C9-2502084954A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31119290-87924D99-F092-4507-97C9-2502084954A8
Analysis of Real-World Data on Overall Survival in Multiple Myeloma Patients With ≥3 Prior Lines of Therapy Including a Proteasome Inhibitor (PI) and an Immunomodulatory Drug (IMiD), or Double Refractory to a PI and an IMiD.
P2860
Q31119290-87924D99-F092-4507-97C9-2502084954A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31119290-87924D99-F092-4507-97C9-2502084954A8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d523f8015e42328ade2fdbe5e6664555e71e280
P2860
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.